These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18276136)

  • 21. Probing the environment of neurotensin whilst bound to the neurotensin receptor by solid state NMR.
    Williamson PT; Bains S; Chung C; Cooke R; Watts A
    FEBS Lett; 2002 May; 518(1-3):111-5. PubMed ID: 11997028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
    Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
    J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.
    Carraway RE; Hassan S; Cochrane DE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):93-107. PubMed ID: 16406549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.
    Lundquist JT; Dix TA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2579-82. PubMed ID: 10498212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells.
    Liu F; Yang P; Baez M; Ni B
    J Cell Biochem; 2004 Jun; 92(3):603-11. PubMed ID: 15156571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of neurotensin and its receptors in pituitary adenomas.
    Giorgi RR; Chile T; Bello AR; Reyes R; Fortes MA; Machado MC; Cescato VA; Musolino NR; Bronstein MD; Giannella-Neto D; Corrêa-Giannella ML
    J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin receptors in adeno- and squamous cell carcinoma.
    Haase C; Bergmann R; Oswald J; Zips D; Pietzsch J
    Anticancer Res; 2006; 26(5A):3527-33. PubMed ID: 17094477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis.
    Bossard C; Souazé F; Jarry A; Bezieau S; Mosnier JF; Forgez P; Laboisse CL
    Peptides; 2007 Oct; 28(10):2030-5. PubMed ID: 17870207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist.
    Cusack B; Jansen K; McCormick DJ; Chou T; Pang Y; Richelson E
    Biochem Pharmacol; 2000 Sep; 60(6):793-801. PubMed ID: 10930533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
    Mascarin A; Valverde IE; Vomstein S; Mindt TL
    Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of neurotensin(8-13)-phosphopeptide heterodimers via click chemistry.
    Richter S; Ramenda T; Bergmann R; Kniess T; Steinbach J; Pietzsch J; Wuest F
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3306-9. PubMed ID: 20452768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.
    Geisler S; Bérod A; Zahm DS; Rostène W
    Peptides; 2006 Oct; 27(10):2364-84. PubMed ID: 16934369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide.
    Jia Y; Zhang W; Fan W; Brusnahan S; Garrison J
    Bioconjug Chem; 2016 Nov; 27(11):2658-2668. PubMed ID: 27661393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Keller M; Kuhn KK; Einsiedel J; Hübner H; Biselli S; Mollereau C; Wifling D; Svobodová J; Bernhardt G; Cabrele C; Vanderheyden PM; Gmeiner P; Buschauer A
    J Med Chem; 2016 Mar; 59(5):1925-45. PubMed ID: 26824643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
    Pettibone DJ; Hess JF; Hey PJ; Jacobson MA; Leviten M; Lis EV; Mallorga PJ; Pascarella DM; Snyder MA; Williams JB; Zeng Z
    J Pharmacol Exp Ther; 2002 Jan; 300(1):305-13. PubMed ID: 11752130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
    Pang YP; Cusack B; Groshan K; Richelson E
    J Biol Chem; 1996 Jun; 271(25):15060-8. PubMed ID: 8663052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13).
    Sousbie M; Vivancos M; Brouillette RL; Besserer-Offroy É; Longpré JM; Leduc R; Sarret P; Marsault É
    J Med Chem; 2018 Aug; 61(16):7103-7115. PubMed ID: 30035538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
    Heyl DL; Sefler AM; He JX; Sawyer TK; Wustrow DJ; Akunne HC; Davis MD; Pugsley TA; Heffner TG; Corbin AE
    Int J Pept Protein Res; 1994 Sep; 44(3):233-8. PubMed ID: 7822099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand.
    Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR
    Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.